Literature DB >> 2515167

Experimental allergic encephalomyelitis in the monkey: humoral immunity and blood-brain barrier function.

P Gallo1, D Cupic, F Bracco, L Krzalic, B Tavolato, L Battistin.   

Abstract

Acute monophasic experimental autoimmune encephalomyelitis (AMEAE) was induced in 5 Macacus cynomolgus monkeys. Serum and cerebrospinal fluid (CSF) paired samples were collected before and four weeks after immunization, time of complete development of AMEAE clinical picture. After immunization the CSF/serum albumin ratio and the IgG index were markedly increased. Agarose isoelectric focusing (AIEF) followed by immunofixation revealed faint IgG oligoclonal bands in both serum and CSF of all monkeys, which became more evident after Kappa and Lambda assessment. Intrathecal synthesis of IgG oligoclonal bands was detected in only one CSF. Affinity-driven immunoblotting failed to detect anti-myelin basic protein (MBP) oligoclonal IgG. No free light chain (FLC) patterns or IgA and IgM oligoclonal bands were detected.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2515167     DOI: 10.1007/bf02333791

Source DB:  PubMed          Journal:  Ital J Neurol Sci        ISSN: 0392-0461


  27 in total

1.  Chronic experimental allergic encephalomyelitis in monkeys.

Authors:  A FERRARO; C L CAZZULLO
Journal:  J Neuropathol Exp Neurol       Date:  1948-07       Impact factor: 3.685

2.  Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values.

Authors:  G Tibbling; H Link; S Ohman
Journal:  Scand J Clin Lab Invest       Date:  1977-09       Impact factor: 1.713

Review 3.  Neuroimmunologic diseases: effector cell responses and immunoregulatory mechanisms.

Authors:  P Y Paterson; E D Day; C C Whitacre
Journal:  Immunol Rev       Date:  1981       Impact factor: 12.988

4.  Changes in the effectiveness of the blood-brain and blood-spinal cord barriers in experimental allergic encephalomyelitis.

Authors:  P M Daniel; D K Lam; O E Pratt
Journal:  J Neurol Sci       Date:  1981 Nov-Dec       Impact factor: 3.181

5.  Chronic relapsing experimental allergic encephalomyelitis. Immunological and blood--cerebrospinal fluid barrier-dependent changes in the cerebrospinal fluid.

Authors:  A J Suckling; H Reiber; J A Kirby; M G Rumsby
Journal:  J Neuroimmunol       Date:  1983-02       Impact factor: 3.478

6.  Free light chains in multiple sclerosis and infections of the CNS.

Authors:  C DeCarli; M A Menegus; R A Rudick
Journal:  Neurology       Date:  1987-08       Impact factor: 9.910

7.  Chronic experimental allergic encephalomyelitis in rhesus monkeys and its modification by treatment.

Authors:  L Ravkina; V Rogova; L Lazarenko
Journal:  J Neurol Sci       Date:  1978-10       Impact factor: 3.181

8.  Autoimmune encephalomyelitis and hemorrhagic retinal disease in neonatal, infant, juvenile, and adult monkeys.

Authors:  E M Lerner; S H Stone; R E Myers
Journal:  J Neuroimmunol       Date:  1985 Feb-Mar       Impact factor: 3.478

9.  Specificity of oligoclonal IgG bands in sera from chronic relapsing experimental allergic encephalomyelitis guinea pigs.

Authors:  P D Mehta; B A Patrick; H M Wisniewski
Journal:  J Immunol       Date:  1985-04       Impact factor: 5.422

10.  Multiple sclerosis: free light chains in cerebrospinal fluid.

Authors:  R A Rudick; D R Peter; J M Bidlack; D W Knutson
Journal:  Neurology       Date:  1985-10       Impact factor: 9.910

View more
  3 in total

Review 1.  Progress and prospects for genetic modification of nonhuman primate models in biomedical research.

Authors:  Anthony W S Chan
Journal:  ILAR J       Date:  2013

2.  Cryopreservation of transgenic Huntington's disease rhesus macaque sperm-A Case Report.

Authors:  Kittiphong Putkhao; Anthony W S Chan; Yuksel Agca; Rangsun Parnpai
Journal:  Cloning Transgenes       Date:  2013

Review 3.  Generation of genetically-engineered animals using engineered endonucleases.

Authors:  Jong Geol Lee; Young Hoon Sung; In-Jeoung Baek
Journal:  Arch Pharm Res       Date:  2018-05-17       Impact factor: 4.946

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.